Cover Image

Acquired perforating dermatosis associated with risankizumab

Saved in:

Bibliographic Details
Main Authors:	Munira Alhadlg, MD (Author), Ghadah Alhammad, MD (Author), Abdulaziz Madani, MD (Author)
Format:	Book
Published:	Elsevier, 2024-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cabozantinib-associated acquired perforating dermatosis
by: Denis Smirnov, MD, PhD, et al.
Published: (2024)

Acquired perforating dermatosis in patients with copper deficiency
by: Jeffrey Alex Varghese, BS, et al.
Published: (2021)

Acquired perforating dermatosis in the setting of hepatocellular carcinoma
by: Reinaldo Tovo Filho, MD, PhD, et al.
Published: (2021)

Dupilumab in acquired perforating dermatosis: A potential new treatment
by: Musaed M. Alsebayel, MD, et al.
Published: (2022)

Giant variant of acquired perforating dermatosis in a renal dialysis patient
by: Lauren Metterle, BS, et al.
Published: (2017)

Pembrolizumab‐induced acquired perforating dermatosis
by: Yaron Gu, et al.
Published: (2024)

Treatment of acquired perforating dermatosis with colchicine
by: Geetali Kharghoria, et al.
Published: (2022)

Successful treatment of acquired perforating dermatosis with colchicine
by: Francisco Gil, et al.
Published: (2021)

Acquired perforating dermatosis successfully treated with dupilumab
by: Omar Alwattar‐Ceballos, et al.
Published: (2023)

Acquired reactive perforating dermatosis successfully treated with allopurinol
by: Ana Gusmão Palmeiro, et al.
Published: (2024)

Treatment of a perforating dermatosis with apremilast
by: Josette McMichael, MD, et al.
Published: (2021)

Successful Use of Dupilumab in the Treatment of Acquired Perforating Dermatosis Associated with Atopic Dermatitis
by: Niccolò Gori, et al.
Published: (2024)

Acquired perforating dermatosis in a patient with chronic renal failure
by: Karen de Almeida Pinto Fernandes, et al.
Published: (2016)

Erythrodermic Psoriasis Managed with Risankizumab
by: Abdulmajeed Alajlan, et al.
Published: (2022)

Risankizumab-associated lichen planus pemphigoides
by: Jessica Sparks, et al.
Published: (2023)

The use of common salt for the treatment of pyogenic granuloma
by: Ghadah Alhammad, MD, et al.
Published: (2024)

Acquired Perforating Dermatosis: Clinical and Histopathological Analysis of 95 Patients From One Center
by: Yusuf Can Edek, et al.
Published: (2024)

Use of risankizumab in two HIV-positive patients with psoriasis
by: Khalad Maliyar, MD, BA, et al.
Published: (2023)

Perforating dermatosis in a patient receiving azathioprine
by: Emiliano Grillo, et al.
Published: (2013)

Refractory dissecting cellulitis of the scalp treated with risankizumab: 2 case reports
by: Khalid Nabil Nagshabandi, MBBS, et al.
Published: (2023)

Osimertinib-associated ashy dermatosis-like hyperpigmentation
by: Pattamon Lertpichitkul, MD, et al.
Published: (2020)

Clinical efficacy of risankizumab in patients with psoriasis: A Japanese case series
by: Kanako Tsunoda, MD, PhD, et al.
Published: (2024)

A potential new treatment with upadacitinib for acquired reactive perforating collagenosis
by: Wei Ding, BS, et al.
Published: (2024)

Mycosis fungoides diagnosed after exposure to risankizumab for psoriasis
by: Lauren M. Fahmy, BS, et al.
Published: (2023)

Successful treatment of psoriasis with risankizumab in a patient with telangiectasia macularis eruptiva perstans
by: Cara Barber, MD, MPH, et al.
Published: (2022)

New-onset systemic lupus erythematous in a patient receiving risankizumab for psoriasis
by: Cara Barber, MD, MPH, et al.
Published: (2022)

Scabies‐induced perforating dermatosis successfully treated with low dose methotrexate
by: Elena Ippoliti, et al.
Published: (2024)

Pruritic periumbilical plaque as a presentation of a rare perforating dermatosis
by: Meghana Bathina, et al.
Published: (2020)

Dermatose perfurante adquirida associada à insuficiência hepática em paciente transplantado de fígado Acquired perforating dermatosis associated with hepatic failure in a liver-transplanted patient
by: Daniela Badziak, et al.
Published: (2007)

Successful management of a severe case of chronic giant acquired reactive perforating collagenosis with allopurinol
by: Aryan Naik, BS, et al.
Published: (2023)

Nivolumab-induced psoriasis successfully treated with risankizumab-rzaa in a patient with stage III melanoma
by: George D. Glinos, MD, et al.
Published: (2021)

Risankizumab for the treatment of pityriasis rubra pilaris postanaplastic large cell lymphoma
by: Georgia Koroneos, BSc, MD, et al.
Published: (2024)

Asymptomatic SARS-CoV2 infection in a patient receiving risankizumab, an inhibitor of interleukin 23
by: Madison Ward, BSc, MD, et al.
Published: (2021)

"Peeling paint" dermatosis in a leukemia patient
by: Margit Juhasz, MD, et al.
Published: (2020)

Carpenter's pigmentation mimicking ashy dermatosis associated with African padauk wood dust
by: Yiming Li, MD, PhD, et al.
Published: (2018)

Tacalcitol in the Treatment of Acquired Perforating Collagenosis
by: J.C. Escribano-Stablé, et al.
Published: (2014)

Dermoscopy in assisting the recognition of ashy dermatosisKey messages
by: Enzo Errichetti, MD, et al.
Published: (2017)

Post-zoster eosinophilic dermatosis and acquired tufted angioma: Isotopic response
by: Young Shin Kim, et al.
Published: (2022)

Treatment of transient acantholytic dermatosis with liquid nitrogen
by: Jayden Galamgam, MD, et al.
Published: (2020)

Neutrophilic Dermatosis in Myelodysplastic Syndrome and Chronic Active Hepatitis C
by: Rupam Sharma MD, et al.
Published: (2021)